Is UnitedHealth Group, Inc. overvalued or undervalued?

Jun 25 2025 08:23 AM IST
share
Share Via
As of October 5, 2023, UnitedHealth Group, Inc. is considered attractive and undervalued with a P/E ratio of 20.5, a P/B ratio of 4.0, and a 25% ROE, despite trading at a premium compared to peers like Anthem and Cigna, due to its strong growth prospects and recent outperformance against the Sensex.
As of 5 October 2023, UnitedHealth Group, Inc. has moved from fair to attractive based on its recent performance and valuation metrics. The company is currently undervalued. Key ratios include a Price-to-Earnings (P/E) ratio of 20.5, a Price-to-Book (P/B) ratio of 4.0, and a Return on Equity (ROE) of 25%.

In comparison to its peers, Anthem, Inc. has a P/E ratio of 18.0, while Cigna Corporation stands at a P/E of 15.5. This suggests that UnitedHealth is trading at a premium relative to its peers, yet its strong growth prospects and profitability justify this valuation. Additionally, UnitedHealth has outperformed the Sensex in recent months, reinforcing the attractiveness of its current valuation.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News